newsfilter
← Latest News
Business Wire·

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities

Financing priced at a premium; led by healthcare-focused institutional investor Nantahala Capital with participation from existing Quince stockholders including ADAR1 Capital Management, along with members of Quince's